These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
402 related articles for article (PubMed ID: 31888585)
1. The overexpression of peroxiredoxin-4 affects the progression of idiopathic pulmonary fibrosis. Hanaka T; Kido T; Noguchi S; Yamada S; Noguchi H; Guo X; Nawata A; Wang KY; Oda K; Takaki T; Izumi H; Ishimoto H; Yatera K; Mukae H BMC Pulm Med; 2019 Dec; 19(1):265. PubMed ID: 31888585 [TBL] [Abstract][Full Text] [Related]
2. Surfactant protein A as a biomarker of outcomes of anti-fibrotic drug therapy in patients with idiopathic pulmonary fibrosis. Yoshikawa T; Otsuka M; Chiba H; Ikeda K; Mori Y; Umeda Y; Nishikiori H; Kuronuma K; Takahashi H BMC Pulm Med; 2020 Jan; 20(1):27. PubMed ID: 32005219 [TBL] [Abstract][Full Text] [Related]
3. Serum heat shock protein 47 levels are elevated in acute exacerbation of idiopathic pulmonary fibrosis. Kakugawa T; Yokota S; Ishimatsu Y; Hayashi T; Nakashima S; Hara S; Sakamoto N; Kubota H; Mine M; Matsuoka Y; Mukae H; Nagata K; Kohno S Cell Stress Chaperones; 2013 Sep; 18(5):581-90. PubMed ID: 23435730 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Diagnostic Efficacies of Serological Markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in Idiopathic Interstitial Pneumonia. Xue M; Guo Z; Cai C; Sun B; Wang H Respiration; 2019; 98(6):534-545. PubMed ID: 31665737 [TBL] [Abstract][Full Text] [Related]
5. CSF3 aggravates acute exacerbation of pulmonary fibrosis by disrupting alveolar epithelial barrier integrity. Guo B; Liu W; Ji X; Xi B; Meng X; Xie W; Sun Y; Zhang M; Liu P; Zhang W; Yan X; Chen B Int Immunopharmacol; 2024 Jun; 135():112322. PubMed ID: 38788452 [TBL] [Abstract][Full Text] [Related]
6. Comparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary Fibrosis. Hamai K; Iwamoto H; Ishikawa N; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N; Kohno N Dis Markers; 2016; 2016():4759040. PubMed ID: 27293304 [TBL] [Abstract][Full Text] [Related]
7. Gremlin-1 for the Differential Diagnosis of Idiopathic Pulmonary Fibrosis Versus Other Interstitial Lung Diseases: A Clinical and Pathophysiological Analysis. Aoshima Y; Enomoto Y; Muto S; Meguro S; Kawasaki H; Kosugi I; Fujisawa T; Enomoto N; Inui N; Nakamura Y; Suda T; Iwashita T Lung; 2021 Jun; 199(3):289-298. PubMed ID: 33770226 [TBL] [Abstract][Full Text] [Related]
8. The usefulness of KL-6 and SP-D for the diagnosis and management of chronic hypersensitivity pneumonitis. Okamoto T; Fujii M; Furusawa H; Tsuchiya K; Miyazaki Y; Inase N Respir Med; 2015 Dec; 109(12):1576-81. PubMed ID: 26481343 [TBL] [Abstract][Full Text] [Related]
9. The elevation of serum napsin A in idiopathic pulmonary fibrosis, compared with KL-6, surfactant protein-A and surfactant protein-D. Samukawa T; Hamada T; Uto H; Yanagi M; Tsukuya G; Nosaki T; Maeda M; Hirano T; Tsubouchi H; Inoue H BMC Pulm Med; 2012 Sep; 12():55. PubMed ID: 22963039 [TBL] [Abstract][Full Text] [Related]
10. Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study. Huang TH; Kuo CW; Chen CW; Tseng YL; Wu CL; Lin SH BMC Pulm Med; 2021 May; 21(1):165. PubMed ID: 33992083 [TBL] [Abstract][Full Text] [Related]
11. Lipocalin-2 as a prognostic marker in patients with acute exacerbation of idiopathic pulmonary fibrosis. Tanahashi H; Iwamoto H; Yamaguchi K; Sakamoto S; Horimasu Y; Masuda T; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N Respir Res; 2024 May; 25(1):195. PubMed ID: 38704585 [TBL] [Abstract][Full Text] [Related]
12. IL-17A contributes to HSV1 infection-induced acute lung injury in a mouse model of pulmonary fibrosis. Chen T; Qiu H; Zhao MM; Chen SS; Wu Q; Zhou NY; Lu LQ; Song JC; Tang DL; Weng D; Li HP J Cell Mol Med; 2019 Feb; 23(2):908-919. PubMed ID: 30378252 [TBL] [Abstract][Full Text] [Related]
13. Serum high-mobility group box 1 is associated with the onset and severity of acute exacerbation of idiopathic pulmonary fibrosis. Yamaguchi K; Iwamoto H; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N Respirology; 2020 Mar; 25(3):275-280. PubMed ID: 31270920 [TBL] [Abstract][Full Text] [Related]
14. Prognostic evaluation of serum ferritin in acute exacerbation of idiopathic pulmonary fibrosis. Enomoto N; Oyama Y; Enomoto Y; Mikamo M; Karayama M; Hozumi H; Suzuki Y; Kono M; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T Clin Respir J; 2018 Aug; 12(8):2378-2389. PubMed ID: 29873202 [TBL] [Abstract][Full Text] [Related]
15. C-type lectin Mincle initiates IL-17-mediated inflammation in acute exacerbations of idiopathic pulmonary fibrosis. Tao C; Xian H; Nian-Yu Z; Jia-Cui S; Dong W; Hui-Ping L Biomed Pharmacother; 2023 Mar; 159():114253. PubMed ID: 36680813 [TBL] [Abstract][Full Text] [Related]
16. Establishment of the mouse model of acute exacerbation of idiopathic pulmonary fibrosis. Wei YR; Qiu H; Wu Q; Du YK; Yin ZF; Chen SS; Jin YP; Zhao MM; Wang C; Weng D; Li HP Exp Lung Res; 2016; 42(2):75-86. PubMed ID: 27070485 [TBL] [Abstract][Full Text] [Related]
17. Involvement of necroptotic cell death in macrophages in progression of bleomycin and LPS-induced acute exacerbation of idiopathic pulmonary fibrosis. Koike A; Hayashi K; Fujimori K Eur J Pharmacol; 2024 Jun; 972():176572. PubMed ID: 38614381 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of changes in the serum levels of Krebs von den Lungen-6 and surfactant protein-D over time as important biomarkers in idiopathic fibrotic nonspecific interstitial pneumonia. Yamakawa H; Hagiwara E; Ikeda S; Iwasawa T; Otoshi R; Tabata E; Okuda R; Sekine A; Baba T; Iso S; Okudela K; Takemura T; Ogura T Respir Investig; 2019 Sep; 57(5):422-429. PubMed ID: 31003951 [TBL] [Abstract][Full Text] [Related]
19. Plasma microRNAs are associated with acute exacerbation in idiopathic pulmonary fibrosis. Min H; Fan S; Song S; Zhuang Y; Li H; Wu Y; Cai H; Yi L; Dai J; Gao Q Diagn Pathol; 2016 Nov; 11(1):135. PubMed ID: 27881157 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis. Gui X; Qiu X; Tian Y; Xie M; Li H; Gao Y; Zhuang Y; Cao M; Ding H; Ding J; Zhang Y; Cai H Int Immunopharmacol; 2019 May; 70():208-215. PubMed ID: 30851700 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]